Construction and clinical application of a risk model based on N6-methyladenosine regulators for colorectal cancer

The RiskScore model developed based on m6A regulators played a critical role in CRC development and can be considered as a prognosis predictor for patients with the cancer. The present discoveries will facilitate the diagnosis and clinical management of CRC patients.

Authors

Institutions

Publication Details

Journal
PeerJ
Published
2024-12-20
DOI
https://doi.org/10.7717/peerj.18719
Citations
2
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
0.47
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Construction and clinical application of a risk model based on N6-methyladenosine regulators for colorectal cancer

Hanhan Zhu, Zhen-feng Zhou, Yang Yu
2 citations
PeerJ
RNA modifications and cancer
0.47
article

Construction and clinical application of a risk model based on N6-methyladenosine regulators for colorectal cancer

Hanhan Zhu, Zhen-feng Zhou, Yang Yu
article en
2 citations

Abstract

The RiskScore model developed based on m6A regulators played a critical role in CRC development and can be considered as a prognosis predictor for patients with the cancer. The present discoveries will facilitate the diagnosis and clinical management of CRC patients.

PeerJVol. 12
Jinan University (CN), First Affiliated Hospital of Jinan University (CN)
Partnerships for the goals
Openalex Percentile: Top 33%
RNA modifications and cancer
0.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.